Project description
Rapid diagnostics for COVID-19
The control of disease outbreaks requires rapid and accurate diagnostic tests. So far, testing for COVID-19 has relied on methods suited only for well-equipped centralised laboratories. The scope of the EU-funded CORONADX project is to develop tests that can be performed by minimally or briefly trained personnel at primary healthcare units, mobile laboratories or even at home. These include point-of-care tests for first-line diagnosis and second-line diagnostics that require portable equipment. Their development will be supported by clinical and molecular epidemiological studies. The project's deliverables will facilitate the fast detection and surveillance of the COVID-19 pandemic, contributing to the clinical management of infected patients.
Fields of science
Programme(s)
Funding Scheme
RIA - Research and Innovation actionCoordinator
2800 Kongens Lyngby
Denmark
See on map
Participants (9)
1090 Wien
See on map
2300 Kobenhavn S
See on map
412 51 Goteborg
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
Participation ended
554 48 Jonkoping
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
510275 Guangzhou
See on map
20132 Milano
See on map
26900 Lodi
See on map
102206 Beijing
See on map
554 48 Jonkoping
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.